<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Allergy</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Allergy</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский Аллергологический Журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1810-8830</issn><issn publication-format="electronic">2686-682X</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">16901</article-id><article-id pub-id-type="doi">10.36691/RJA16901</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original studies</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Characteristics of the molecular sensitization profiles in patients with birch pollen allergy and cross-reactive food allergy to PR-10 proteins</article-title><trans-title-group xml:lang="ru"><trans-title>Особенности молекулярного профиля сенсибилизации у пациентов с аллергией на пыльцу берёзы и перекрёстной пищевой аллергией к PR-10 белкам</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5021-9276</contrib-id><contrib-id contrib-id-type="spin">2337-7930</contrib-id><name-alternatives><name xml:lang="en"><surname>Litovkina</surname><given-names>Alla O.</given-names></name><name xml:lang="ru"><surname>Литовкина</surname><given-names>Алла Олеговна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>dr.litovkina@gmail.com</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9858-7596</contrib-id><contrib-id contrib-id-type="spin">4317-9042</contrib-id><name-alternatives><name xml:lang="en"><surname>Byazrova</surname><given-names>Maria G.</given-names></name><name xml:lang="ru"><surname>Бязрова</surname><given-names>Мария Георгиевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>mbyazrova@list.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1302-4178</contrib-id><contrib-id contrib-id-type="spin">4874-8100</contrib-id><name-alternatives><name xml:lang="en"><surname>Smolnikov</surname><given-names>Evgeniy V.</given-names></name><name xml:lang="ru"><surname>Смольников</surname><given-names>Евгений Валентинович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>qwertil2010@yandex.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0003-0737-454X</contrib-id><contrib-id contrib-id-type="spin">6273-3070</contrib-id><name-alternatives><name xml:lang="en"><surname>Aplevich</surname><given-names>Oleg V.</given-names></name><name xml:lang="ru"><surname>Аплевич</surname><given-names>Олег Валерьевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>aplevich-ov@rudn.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3358-5087</contrib-id><contrib-id contrib-id-type="spin">5012-7242</contrib-id><name-alternatives><name xml:lang="en"><surname>Fedenko</surname><given-names>Elena S.</given-names></name><name xml:lang="ru"><surname>Феденко</surname><given-names>Елена Сергеевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.), Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор</p></bio><email>efedks@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">National Research Center ― Institute of Immunology Federal Medical-Biological Agency of Russia</institution></aff><aff><institution xml:lang="ru">Государственный научный центр «Институт иммунологии»</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Peoples' Friendship University of Russia</institution></aff><aff><institution xml:lang="ru">Российский университет дружбы народов имени Патриса Лумумбы</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2023-12-21" publication-format="electronic"><day>21</day><month>12</month><year>2023</year></pub-date><pub-date date-type="pub" iso-8601-date="2023-12-02" publication-format="electronic"><day>02</day><month>12</month><year>2023</year></pub-date><volume>20</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>464</fpage><lpage>475</lpage><history><date date-type="received" iso-8601-date="2023-11-07"><day>07</day><month>11</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-12-05"><day>05</day><month>12</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2023, Pharmarus Print Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2023, Фармарус Принт Медиа</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="en">Pharmarus Print Media</copyright-holder><copyright-holder xml:lang="ru">Фармарус Принт Медиа</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2026-02-02"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref></license></permissions><self-uri xlink:href="https://rusalljournal.ru/raj/article/view/16901">https://rusalljournal.ru/raj/article/view/16901</self-uri><abstract xml:lang="en"><p><bold><italic>BACKGROUND:</italic></bold><italic> </italic>Birch pollen allergy is widespread and is the main allergic disease in Russia. Cross-reactive food allergy, often found in patients with birch pollen allergy, is an underestimated problem that complicates the course of pollinosis and requires further study to improve the quality of diagnosis and personalized recommendations for such patients.</p> <p><bold><italic>AIM:</italic></bold><italic> </italic>To study the features of the molecular sensitization profile of adult patients with birch pollen allergy and cross-reactive food allergy to PR-10 proteins.</p> <p><bold><italic>MATERIALS AND METHODS:</italic></bold><italic> </italic>Twenty-five adult patients with confirmed birch pollen allergy, with or without cross-reactive food allergy, were included in an open single-center interventional prospective controlled nonrandomized study. Specific IgE to 112 allergens was determined by multiplex analysis using ImmunoCAP ISAC (ThermoFisher, Sweden). Patients with cross-reactive food allergy completed a validated questionnaire on cross-reactive food allergy symptoms and causative allergens. The primary endpoint of the study was the assessment of the sensitization profile to Bet v 1 and PR-10 proteins (Mal d 1, Ara h 8, Cor a 1.0101, Cor a 1.0401, Act d 8, Api g 1, Pru p 1, and Gly m 4) and the clinical characteristics of the sensitized patients. The secondary endpoint was the comparison of patients with and without cross-reactive food allergy and the evaluation of how sensitization to Bet v 1 and PR-10 homologs can affect clinical manifestations of cross-reactive food allergy in patients.</p> <p><bold><italic>RESULTS</italic></bold><italic>: </italic>The study included 25 patients aged 18–55 years, from which two comparable groups were formed: group 1 consisted of 13 patients with cross-reactive food allergy symptoms and group 2 (without cross-reactive food allergy) consisted of 12 patients who had never experienced cross-reactive food allergy symptoms. Analysis of the sensitization profile to PR-10 allergens revealed similar patterns in both groups; however, sIgE concentrations to all allergens were significantly higher in group 1. A strong correlation was found between the number of triggering products and total IgE level with PR-10 proteins (r=0.81; <italic>p</italic>=0.001). The severity of cross-reactive food allergy symptoms correlated with the total level of IgE to PR-10 proteins (r=0.97; <italic>p</italic> &lt;0.0001). The cutoff level for total sIgE to food PR-10 proteins, equal to 70 ISU-E, allowed us to distinguish patients with only oral allergic syndrome from those with systemic manifestations of cross-reactive food allergy.</p> <p><bold><italic>CONCLUSION:</italic></bold><italic> </italic>The results of the study are applicable in clinical practice and have prognostic value in determining the severity of cross-reactive food allergy.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Обоснование.</bold> Поллиноз, обусловленный аллергией на пыльцу берёзы, широко распространён во всём мире, а в России занимает лидирующую позицию в структуре аллергических заболеваний. Перекрёстная пищевая аллергия, часто встречающаяся у пациентов с аллергией на берёзу, является недооценённой проблемой, которая осложняет течение поллиноза и требует дальнейшего изучения для улучшения качества диагностики и формирования персонифицированных рекомендаций больных.</p> <p><bold>Цель </bold>— изучить особенности профиля молекулярной сенсибилизации у взрослых больных с аллергией на пыльцу берёзы и перекрёстной пищевой аллергией на PR-10 белки.</p> <p><bold>Материалы и методы.</bold> В открытое одноцентровое проспективное контролируемое нерандомизированное исследование включены 25 пациентов в возрасте от 18 до 55 лет с подтверждённой аллергией на пыльцу берёзы с перекрёстной пищевой аллергией (<italic>n</italic>=13; группа 1) и без таковой (<italic>n</italic>=12; группа 2). Специфические IgE к 112 компонентам аллергенов были определены с помощью мультиплексного анализа ImmunoCAP ISAC (ThermoFisher, Швеция). Пациенты с перекрёстной пищевой аллергией заполняли опросник о симптомах перекрёстной пищевой аллергии и причинно-значимых аллергенах. Первичные конечные точки исследования ― оценка профиля сенсибилизации к молекулам Bet v 1 и PR-10 белкам (Mal d 1, Ara h 8, Cor a 1.0101, Cor a 1.0401, Act d 8, Api g 1, Pru p 1, Gly m 4) и клинические характеристики сенсибилизированных пациентов; вторичные конечные точки ― сравнение пациентов с/без перекрёстной пищевой аллергии и оценка влияния сенсибилизации к Bet v 1 и PR-10 белкам на клинические проявления перекрёстной пищевой аллергии у пациентов.</p> <p><bold>Результаты.</bold> При анализе профиля сенсибилизации к PR-10 аллергенам обнаружены схожие паттерны в обеих группах, однако концентрации sIgE ко всем аллергенам были достоверно выше в группе 1. Обнаружена сильная корреляционная связь между числом вызывающих реакцию продуктов и суммарным уровнем IgE к PR-10 белкам (r=0,81; <italic>p</italic>=0,001). Тяжесть симптомов перекрёстной пищевой аллергии коррелировала с суммарным уровнем IgE к PR-10 белкам (r=0,97; <italic>p</italic> &lt;0,0001). Уровень cut-off для суммарных sIgE к пищевым PR-10 белкам 70 ISU-E позволил разделить участников исследования на пациентов с изолированным оральным аллергическим синдромом и пациентов с системными проявлениями перекрёстной пищевой аллергии.</p> <p><bold>Заключение.</bold> Полученные результаты исследования имеют прогностическую ценность в определении тяжести течения перекрёстной пищевой аллергии и применимы в клинической практике.</p></trans-abstract><kwd-group xml:lang="en"><kwd>birch pollen allergy</kwd><kwd>pollen-food syndrome</kwd><kwd>Bet v 1</kwd><kwd>PR-10 family</kwd><kwd>molecular allergy diagnostics</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>аллергия на пыльцу берёзы</kwd><kwd>перекрёстная пищевая аллергия</kwd><kwd>Bet v 1</kwd><kwd>Pr-10 белки</kwd><kwd>молекулярная аллергодиагностика</kwd></kwd-group><funding-group><funding-statement xml:lang="en">This study was supported by Russian Science Foundation, Grant № 23-25-00413 (https://rscf.ru/en/project/23-25-00413/).</funding-statement><funding-statement xml:lang="ru">Исследование выполнено за счёт гранта Российского научного фонда № 23-25-00413 (https://rscf.ru/project/23-25-00413/).</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Biedermann T, Winther L, Till SJ, et al. Birch pollen allergy in Europe. Allergy. 2019;74(7):1237–1248. doi: 10.1111/all.13758</mixed-citation><mixed-citation xml:lang="ru">Biedermann T., Winther L., Till S.J., et al. Birch pollen allergy in Europe // Allergy. 2019. Vol. 74, N 7. P. 1237–1248. doi: 10.1111/all.13758</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Litovkina AO, Fedenko ES, Elisutina OG. Cross-reactive food allergy to PR-10 homologues in birch pollen sensitized patients. Russian J Allergy. 2018;15(6):18–25. doi: 10.36691/RJA94</mixed-citation><mixed-citation xml:lang="ru">Литовкина А.О., Феденко Е.С., Елисютина О.Г. Перекрестная пищевая аллергия к Pr-10-белкам ― гомологам Bet v 1 у больных, сенсибилизированных к пыльце берёзы // Российский аллергологический журнал. 2018. Т. 15, № 6. C. 18–25. doi: 10.36691/RJA94</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Kozulina IE, Kurbacheva OM, Ilina NI. Allergy today. Analysis of new epidemiological data. Russian J Allergy. 2014;11(3):3–10. doi: 10.36691/rja483</mixed-citation><mixed-citation xml:lang="ru">Козулина И.Е., Курбачева О.М., Ильина Н.И. Аллергия сегодня. Анализ новых эпидемиологических данных // Российский аллергологический журнал. 2014. Т. 11, № 3. С. 3–10. doi: 10.36691/rja483</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Uotila R, Kukkonen AK, Pelkonen AS, et al. Cross-sensitization profiles of edible nuts in a birch-endemic area. Allergy. 2016;71(4):514–521. doi: 10.1111/all.12826</mixed-citation><mixed-citation xml:lang="ru">Uotila R., Kukkonen A.K., Pelkonen A.S., et al. Cross-sensitization profiles of edible nuts in a birch-endemic area // Allergy. 2016. Vol. 71, N 4. P. 514–521. doi: 10.1111/all.12826</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Jeon YH. Pollen-food allergy syndrome in children. Clin Exp Pediatr. 2020;63(12):463–468. doi: 10.3345/cep.2019.00780</mixed-citation><mixed-citation xml:lang="ru">Jeon Y.H. Pollen-food allergy syndrome in children // Clin Exp Pediatr. 2020. Vol. 63, N 12. P. 463–468. doi: 10.3345/cep.2019.00780</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Elisyutina O, Lupinek C, Fedenko E, et al. IgE-reactivity profiles to allergen molecules in Russian children with and without symptoms of allergy revealed by micro-array analysis. Pediatr Allergy Immunol. 2021;32(2):251–263. doi: 10.1111/pai.13354</mixed-citation><mixed-citation xml:lang="ru">Elisyutina O., Lupinek C., Fedenko E, et al. IgE-reactivity profiles to allergen molecules in Russian children with and without symptoms of allergy revealed by micro-array analysis // Pediatr Allergy Immunol. 2021. Vol. 32, N 2. P. 251–263. doi: 10.1111/pai.13354</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Allergic rhinitis. Clinical recommendations. Russian Society of Allergologists and Clinical Immunologists, National Medical Association of Otorhinolaryngologists, Union of Pediatricians of Russia; 2022. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Клинические рекомендации «Аллергический ринит». Российская ассоциация аллергологов и клинических иммунологов, Национальная медицинская ассоциация оториноларингологов, Союз педиатров России, 2022.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Bronchial asthma. Clinical recommendations. Russian Respiratory Society, Russian Society of Allergologists and Clinical Immunologists, Union of Pediatricians of Russia; 2023. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Клинические рекомендации «Бронхиальная астма». Российское респираторное общество, Российская ассоциация аллергологов и клинических иммунологов, Союз педиатров России, 2023.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Atopic dermatitis. Clinical recommendations. Russian Society of Dermatovenerologists and Cosmetologists, Russian Society of Allergologists and Clinical Immunologists, Union of Pediatricians of Russia; 2023. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Клинические рекомендации «Атопический дерматит». Российское общество дерматовенерологов и косметологов, Российская ассоциация аллергологов и клинических иммунологов, Союз педиатров России, 2023.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Skypala IJ, Calderon MA, Leeds AR, et al. Development and validation of a structured questionnaire for the diagnosis of oral allergy syndrome in subjects with seasonal allergic rhinitis during the UK birch pollen season. Clin Exp Allergy. 2011;41(7):1001–1011. doi: 10.1111/j.1365-2222.2011.03759.x</mixed-citation><mixed-citation xml:lang="ru">Skypala I.J., Calderon M.A., Leeds A.R., et al. Development and validation of a structured questionnaire for the diagnosis of oral allergy syndrome in subjects with seasonal allergic rhinitis during the UK birch pollen season // Clin Exp Allergy. 2011. Vol. 41, N 7. P. 1001–1011. doi: 10.1111/j.1365-2222.2011.03759.x</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Matricardi PM, Kleine-Tebbe J, Hoffmann HJ, et al. EAACI molecular allergology user's guide. Pediatr Allergy Immunol. 2016;27(Suppl 23):1–250. doi: 10.1111/pai.12563</mixed-citation><mixed-citation xml:lang="ru">Matricardi P.M., Kleine-Tebbe J., Hoffmann H.J., et al. EAACI molecular allergology user's guide // Pediatr Allergy Immunol. 2016. Vol. 27, N 23 P. 1–250. doi: 10.1111/pai.12563</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Elisyutina O, Fedenko E, Campana R, et al. Bet v 1-specific IgE levels and PR-10 reactivity discriminate silent sensitization from phenotypes of birch allergy. Allergy. 2019;74(12):2525–2528. doi: 10.1111/all.13931</mixed-citation><mixed-citation xml:lang="ru">Elisyutina O., Fedenko E., Campana R., et al. Bet v 1-specific IgE levels and PR-10 reactivity discriminate silent sensitization from phenotypes of birch allergy // Allergy. 2019. Vol. 74, N 12. P. 2525–2528. doi: 10.1111/all.13931</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Asero R. Effects of birch pollen-specific immunotherapy on apple allergy in birch pollen-hypersensitive patients. Clin Exp Allergy. 1998;28(11):1368–1373. doi: 10.1046/j.1365-2222.1998.00399.x</mixed-citation><mixed-citation xml:lang="ru">Asero R. Effects of birch pollen-specific immunotherapy on apple allergy in birch pollen-hypersensitive patients // Clin Exp Allergy. 1998. Vol. 28, N 11. P. 1368–1373. doi: 10.1046/j.1365-2222.1998.00399.x</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Bucher X, Pichler WJ, Dahinden CA, et al. Effect of tree pollen specific, subcutaneous immunotherapy on the oral allergy syndrome to apple and hazelnut. Allergy. 2004;59(12):1272–1276. doi: 10.1111/j.1398-9995.2004.00626.x</mixed-citation><mixed-citation xml:lang="ru">Bucher X., Pichler W.J., Dahinden C.A., et al. Effect of tree pollen specific, subcutaneous immunotherapy on the oral allergy syndrome to apple and hazelnut // Allergy. 2004. Vol. 59, N 12. P. 1272–1276. doi: 10.1111/j.1398-9995.2004.00626.x</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Lam HC, Jarvis D; ECRHS I Investigators. Seasonal variation in total and pollen-specific immunoglobulin E levels in the European Community Respiratory Health Survey. Clin Exp Allergy. 2021;51(8):1085–1088. doi: 10.1111/cea.13895</mixed-citation><mixed-citation xml:lang="ru">Lam H.C., Jarvis D.; ECRHS I Investigators. Seasonal variation in total and pollen-specific immunoglobulin E levels in the European Community Respiratory Health Survey // Clin Exp Allergy. 2021. Vol. 51, N 8. P. 1085–1088. doi: 10.1111/cea.13895</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Niederberger V, Ring J, Rakoski J, et al. Antigens drive memory IgE responses in human allergy via the nasal mucosa. Int Arch Allergy Immunol. 2007;142(2):133–144. doi: 10.1159/000096439</mixed-citation><mixed-citation xml:lang="ru">Niederberger V., Ring J., Rakoski J., et al. Antigens drive memory IgE responses in human allergy via the nasal mucosa // Int Arch Allergy Immunol. 2007. Vol. 142, N 2. P. 133–144. doi: 10.1159/000096439</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Litovkina A, Byazrova M, Smolnikov E, et al. Allergic sensitization to Mal d 1 without detectable specific serum IgE. Pediatr Allergy Immunol. 2022;33(12):e13891. doi: 10.1111/pai.13891</mixed-citation><mixed-citation xml:lang="ru">Litovkina A., Byazrova M., Smolnikov E., et al. Allergic sensitization to Mal d 1 without detectable specific serum IgE // Pediatr Allergy Immunol. 2022. Vol. 33, N 12. P. 1–5. doi: 10.1111/pai.13891</mixed-citation></citation-alternatives></ref></ref-list></back></article>
